Heroin is cheaper to buy than methadone when the choice is withdrawal or relapse
In Cape Town, the slow withdrawal of American health funding has reached the bodies of those least able to absorb the shock — people in recovery from heroin addiction, whose access to methadone became as unpredictable as the political decisions made half a world away. What unfolded at a drop-off point on Adderley Street is a small but precise illustration of how global policy choices translate into personal collapse: when the medication disappeared, the addiction returned. The NGO holding the programme together has since steadied itself, but the architecture of dependency on foreign goodwill remains intact, and fragile.
- Men and women managing heroin addiction through methadone suddenly found themselves receiving two or three days' supply at a time — or nothing at all — as US funding cuts rippled through Cape Town's harm reduction clinics.
- For those in recovery, the gaps were not administrative inconveniences but physiological crises: withdrawal set in, heroin became the cheaper and more available alternative, and years of hard-won progress unravelled in days.
- The root cause was not a shortage of methadone in South Africa but a collapse in the funding architecture — PEPFAR cuts and a Global Fund allocation reduced to a quarter of its previous cycle left TB HIV Care competing for scraps of international donor money.
- Peer outreach workers at Streetscapes improvised where institutions failed, covering pharmacy costs out of their own limited budgets to keep individuals like Jade Lewis from losing everything — including a job opportunity that required a month's supply he could not obtain.
- TB HIV Care says the funding transition has now been navigated and services have stabilised, but the programme's survival still depends on international political goodwill — a dependency that offers no structural protection against the next round of cuts.
Jade Lewis arrived at the TB HIV Care drop-off on Adderley Street one February morning expecting his weekly methadone. He left with nothing. When he returned in April, the same thing happened. In the weeks that followed, supply became erratic — sometimes two days' worth, sometimes three. When the methadone ran out, Lewis returned to heroin to manage the withdrawal.
At 44, Lewis has spent two decades navigating addiction — cocaine first, then tik, then heroin from 2005 onward. Trauma compounded the habit: a sexual assault in his school years, his sister's death in 2011, the end of his marriage in 2019. Last November, he had enrolled again in a methadone programme through TB HIV Care and Streetscapes, a peer outreach organisation. He was living in a shelter, earning a stipend, and had found a fragile foothold. The supply disruptions cost him a job opportunity — a potential employer needed confirmation of a month's supply, which TB HIV Care could not provide. Lewis had to let it go.
The problem was not a national shortage. TB HIV Care confirmed methadone was available in South Africa. The issue was funding. The organisation's harm reduction programme had relied on US government health support through PEPFAR and the Global Fund. When the Trump administration cut global health spending, the Global Fund's allocation to South Africa fell to a quarter of its previous cycle. TB HIV Care found itself competing with other organisations for a dramatically reduced pool of donor money.
Peer facilitator Rudie Basson explained the brutal economics: a 35-millilitre dose of methadone costs between 200 and 300 rand. Heroin is cheaper. When withdrawal is the alternative, the calculation is simple. Streetscapes stepped in for Lewis — accompanying him to a private doctor and covering roughly 283 rand for a five-day pharmacy supply. A temporary lifeline from an organisation with its own limited means.
TB HIV Care's communications manager attributed the disruptions to a funding transition requiring operational adjustments, and said services had since stabilised. But the underlying exposure has not changed. For people like Lewis, who have spent years clawing toward recovery, the difference between stability and relapse now depends on whether Washington's political priorities happen to align with their survival.
Jade Lewis showed up at the TB HIV Care drop-off on Adderley Street in Cape Town one February morning expecting to collect his weekly dose of methadone. He left empty-handed. The medication he depends on to manage his heroin addiction—a habit that has consumed him since 2005—simply wasn't there. When he returned in April, the same thing happened. Over the following weeks, the supply became a lottery: some days he'd receive enough for three days, other times just two. When the methadone ran out, Lewis did what many people in his situation do. He used heroin to manage the withdrawal symptoms—the body shakes, the spasms, the sensation of being unable to concentrate or focus on anything but the craving.
Lewis is 44 now, and his path to this moment has been long and fractured. He first used cocaine in 2001, then moved to tik, then heroin in 2005. That year, he says, his whole life changed. He was working for the government at the time, managing to hold the job even as the drug slowly consumed him. An incident of sexual assault in his final year of school, his sister's death in 2011, and the collapse of his marriage in 2019 all deepened his dependence. He has cycled through recovery programmes since 2014. Last November, he enrolled again in the methadone programme through TB HIV Care and Streetscapes, a peer outreach organization. He was living in a shelter for adults and earning a stipend from work at Streetscapes and by wrapping bags for long-distance bus travellers. For the first time in years, he had a foothold.
Then the methadone access collapsed. The disruptions cost him a job opportunity—a potential employer needed him to have a month's supply secured, but TB HIV Care couldn't provide it. Lewis had to let the opportunity go. The incident sent him back to heroin. It was a concrete reminder of how fragile recovery is when the medication that anchors it becomes unreliable.
The problem was not a shortage of methadone in South Africa. TB HIV Care, the NGO running the programme, confirmed there was no national shortage. The issue was funding. The organization's People Who Inject Drugs programme had been supported by US government health funding—specifically through PEPFAR (the President's Emergency Plan for AIDS Relief) via the US Centers for Disease Control, and through the Global Fund to Fight AIDS, TB and Malaria. When the Trump administration slashed US funding for global health, the landscape shifted dramatically. The Global Fund's allocation to South Africa dropped to just a quarter of what it had been in the previous three-year cycle. TB HIV Care suddenly found itself competing with other organizations for a much smaller pool of international donor money, making it impossible to sustain services at their previous level.
Rudie Basson, a peer outreach facilitator at Streetscapes, explained the bind that people like Lewis face when methadone becomes unavailable. "They might not have the money to buy methadone because it's expensive," Basson said. For a 35-millilitre dose, the cost runs between 200 and 300 South African rand. Heroin is cheaper. When the choice is between withdrawal and relapse, the economics of addiction become brutally simple. In Lewis's case, Streetscapes stepped in. He and Basson visited a private doctor to get a prescription, and Streetscapes covered the cost of methadone from a pharmacy—about 283 rand for a five-day supply. It was a temporary fix, a lifeline thrown by an organization with its own limited resources.
TB HIV Care's communications manager, Aziel Gangerdine, acknowledged the concerns. He said the organization was aware of the recent problems with methadone availability and confirmed that no official announcement of a national shortage had been made. He attributed the disruptions to "a transition in funding" that required "operational and process adjustments" which "temporarily affected service momentum in some areas." He added that these matters had since been addressed and that service delivery had stabilized. The organization, he suggested, now had access to funds to keep the programme going.
But the underlying vulnerability remains. As long as international funding for health programmes in South Africa depends on the political winds in Washington, organizations like TB HIV Care will remain exposed to sudden cuts. For people like Lewis, who has spent two decades fighting addiction and only recently found stable ground, that exposure is not abstract. It is the difference between a job opportunity and a relapse, between a future and a return to the streets.
Citações Notáveis
When the methadone ran out, Lewis used heroin to manage withdrawal symptoms—the body shakes, the spasms, the sensation of being unable to concentrate— Jade Lewis, methadone patient
They might not have the money to buy methadone because it's expensive. Heroin is cheaper to buy.— Rudie Basson, Streetscapes peer outreach facilitator
A Conversa do Hearth Outra perspectiva sobre a história
Why does a funding cut in the US end up affecting someone in Cape Town trying to stay off heroin?
Because TB HIV Care's methadone programme was never funded locally. It relied on US government money flowing through international health channels. When that money stopped, there was no local budget to fall back on.
So the organization knew the funding was coming from America. Couldn't they have planned for this?
They probably did plan for it, but you can't plan your way out of a 75 percent budget cut. The Global Fund's allocation to South Africa dropped to a quarter of what it was. That's not a shortfall you absorb—it's a collapse.
What happens to someone like Jade Lewis when the methadone runs out?
His body goes into withdrawal. He can't work, can't concentrate, can't function. And heroin is cheaper than methadone, so he uses it. He loses the job he was about to start. His recovery, which took months to build, unravels in weeks.
Did TB HIV Care just give up?
No. They're saying service has stabilized now, that they found other funding. But the real question is whether it's sustainable, or whether the next cut will happen again.
Is methadone actually scarce in South Africa?
No. There's no national shortage. The shortage is in the money to pay for it and distribute it. That's a different problem entirely—and it's harder to solve.
What does Streetscapes do?
They're a peer outreach organization. When TB HIV Care couldn't provide methadone, Streetscapes helped Lewis get a private prescription and paid for it themselves. They're filling gaps that the system left open.